News about Global Pharma

Takeda and Biological E. Limited Partners to Accelerate Access to Dengue Vaccine

The collaboration aims to expedite access to QDENGA®?, a Dengue Tetravalent Vaccine (TAK-003) presented in multi-dose vials (MDVs), for government procurement in endemic countries by 2030.

Global Pharma | 27/02/2024 | By Manvi |  369

Pfizer Collaborates with NIPER to support Healthcare Innovation in India

The initiative is being supported by the Department of Pharmaceuticals and Niti Aayog and is being anchored by Social Alpha.

Global Pharma | 27/02/2024 | By Manvi |  827

Travere Therapeutics and CSL Vifor's Sparsentan Recommended for IgA Nephropathy in Europe

IgAN, a rare kidney disease and a leading cause of kidney failure, currently lacks approved non-immunosuppressive treatment options.

Global Pharma | 26/02/2024 | By Manvi |  1090

Orchid Pharma's Enmetazobactam Receives USFDA Approval

This achievement closely follows a recent recommendation for approval by the European Medicines Agency (EMA), positioning Enmetazobactam as the first completely invented-in-India Beta Lactamase Inhibitor.

Global Pharma | 26/02/2024 | By Manvi |  1331

Zimmer Biomet Receives FDA Clearance for ROSA Shoulder System

This approval marks a significant milestone as ROSA Shoulder becomes the world's first robotic surgery system designed specifically for shoulder replacement.

Global Pharma | 23/02/2024 | By Manvi |  625

Immunofoco's IMC001 CAR-T Therapy Receives Dual FDA and CDE Approvals for Gastrointestinal Tumors

IMC001 is an autologous CAR-T cell product targeting EpCAM for infusion, designed to treat EpCAM-positive advanced gastrointestinal tumors, including advanced gastric cancer and gastroesophageal junction adenocarcinoma.

Global Pharma | 23/02/2024 | By Manvi |  576

Everest Medicines' Partner Pfizer's VELSIPITY Receives Approval from European Commission

This approval allows for the treatment of patients 16 years of age and older with moderately to severely active UC who have had an inadequate response, lost response, or were intolerant to conventional therapy or a biological agent.

Global Pharma | 22/02/2024 | By Manvi |  645

Pfizer and Americares India Foundation Announce Remarkable Success of Project Parivartan

The project aimed at demonstrating reduction in infections and in prevalence of multi-drug resistant organisms in small to mid-sized hospitals through infection prevention and control and antimicrobial stewardship activities.

Global Pharma | 22/02/2024 | By Manvi |  1032

Jubilant HollisterStier Expands Facility, Adds Third Sterile Fill Finish Line

The expansion initiative encompasses the installation of a new high-speed commercial fill finish line, housed within a 50,000 square foot facility expansion.

Global Pharma | 22/02/2024 | By Manvi |  281

X-trodes' Smart Skin Receives FDA Clearance for Wireless Wearable Monitoring Technology

This innovative technology represents a new era in wearable monitoring, offering advanced electrophysiological data acquisition without the need for cumbersome wires or gels.

Global Pharma | 21/02/2024 | By Manvi |  735